Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants

Academic Article

Abstract

  • Saquinavir boosted with low-dose ritonavir given with zidovudine and lamivudine was well tolerated by pregnant women and their infants. All mothers had <400 human immunodeficiency virus type 1 RNA copies/ml at delivery. Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia). Copyright © 2007, American Society for Microbiology. All Rights Reserved.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Zorrilla CD; Van Dyke R; Bardeguez A; Acosta EP; Smith B; Hughes MD; Huang S; Watts DH; Heckman B; Jiménez E
  • Start Page

  • 2208
  • End Page

  • 2210
  • Volume

  • 51
  • Issue

  • 6